z-logo
open-access-imgOpen Access
COVID-19 mRNA Vaccine and Myocarditis
Author(s) -
Balraj Singh,
Parminder Kaur,
Leon Cedeno,
Taulant Brahimi,
Prem Patel,
Hartaj Virk,
Fayez Shamoon,
Manesh Bikkina
Publication year - 2021
Publication title -
european journal of case reports in internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 1
ISSN - 2284-2594
DOI - 10.12890/2021_002681
Subject(s) - covid-19 , medicine , virology , myocarditis , viral myocarditis , messenger rna , cardiology , outbreak , biology , disease , infectious disease (medical specialty) , gene , biochemistry
Coronavirus disease 2019 (COVID-19) is believed to have originated in the Hua nan South China Seafood Market in Wuhan and can present with a spectrum of clinical manifestations. We report the case of 24-year-old male patient who developed chest pain after administration of the second dose of the Pfizer-BioNTech mRNA COVID-19 vaccine and who was diagnosed with myocarditis on work-up.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom